Cipher Pharmaceuticals Inc.

TSX:CPH Rapport sur les actions

Capitalisation boursière : CA$374.9m

Cipher Pharmaceuticals Gestion

Gestion contrôle des critères 2/4

Le PDG Cipher Pharmaceuticals est Craig Mull, nommé en Jul2019, a un mandat de 5.33 ans. détient directement 3.19% des actions de la société, d'une valeur de CA$ 11.97M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.5 ans et 3.5 ans.

Informations clés

Craig Mull

Directeur général

US$1.0m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général5.3yrs
Propriété du PDG3.2%
Durée moyenne d'occupation des postes de direction2.5yrs
Durée moyenne du mandat des membres du conseil d'administration3.5yrs

Mises à jour récentes de la gestion

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

PDG

Craig Mull

5.3yrs

Titularisation

US$1,045,700

Compensation

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 12.0m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 73.3k
Emilio Presti
Director of Sales & Marketing2.8yrspas de donnéespas de données
Hamed Ghanei
Chief Business Officerless than a yearpas de donnéespas de données

2.5yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de CPH est considérée comme expérimentée (ancienneté moyenne 2.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 12.0m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 5.4m
Douglas Deeth
Independent Director1.4yrsUS$65.57kpas de données
Hubert Walinski
Independent Director1.4yrsUS$62.57kpas de données

3.5yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de CPH sont considérés comme expérimentés (ancienneté moyenne 3.5 ans).